Chitravanshi Vineet C, Sapru Hreday N
Department of Neurological Surgery, MSB H-586, University of Medicine and Dentistry of New Jersey--New Jersey Medical School, 185 South Orange Ave., Newark, NJ 07103, USA.
Neurosci Lett. 2007 Apr 12;416(2):188-92. doi: 10.1016/j.neulet.2007.02.007. Epub 2007 Feb 7.
Microinjections (30 nl) of nociceptin/orphanin FQ (N/OFQ) into the intermediolateral cell column (IML) at T1 and T2 levels of the spinal cord elicited bradycardia. The decreases in HR were 12.3+/-2.9, 17.3+/-2.7, 26.7+/-3.1, and 18.6+/-3.4 beats/min in response to 0.075, 0.15, 0.62, and 1.25 mM concentrations, respectively. Maximally effective concentration of N/OFQ was 0.62 mM. No changes in BP were elicited by microinjections of N/OFQ into the IML at T1-T2. The bradycardic responses were completely blocked by prior microinjections of a N/OFQ receptor (NOP receptor) antagonist ([N-phe(1)]-nociceptin-(1-13)-NH(2), 9 mM) into the IML at T1-T2. Blockade of myocardial beta-1 adrenergic receptors also abolished the bradycardic responses elicited by microinjections of N/OFQ into the IML. It was concluded that activation of NOP receptors in right IML at T1-T2 by N/OFQ elicited bradycardic responses which were mediated via the sympathetic nervous system.
将30纳升的痛敏肽/孤啡肽FQ(N/OFQ)微量注射到脊髓T1和T2水平的中间外侧细胞柱(IML)中会引发心动过缓。分别给予0.075、0.15、0.62和1.25毫摩尔浓度的N/OFQ后,心率下降分别为12.3±2.9、17.3±2.7、26.7±3.1和18.6±3.4次/分钟。N/OFQ的最大有效浓度为0.62毫摩尔。将N/OFQ微量注射到T1 - T2节段的IML中未引起血压变化。预先将N/OFQ受体(NOP受体)拮抗剂([N - 苯丙氨酸(1)] - 痛敏肽 - (1 - 13) - NH₂,9毫摩尔)微量注射到T1 - T2节段的IML中可完全阻断心动过缓反应。阻断心肌β - 1肾上腺素能受体也可消除将N/OFQ微量注射到IML中所引发的心动过缓反应。得出的结论是,N/OFQ激活T1 - T2节段右侧IML中的NOP受体引发心动过缓反应,该反应通过交感神经系统介导。